Matthew Erik Tenold MD

PubMed

• 3 citations
  Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehen...
  Tamer Othman, Benjamin N Moskoff, Gwendolyn Ho, Matthew E Tenold, Tali Azenkot
  Leukemia Research. 2022-08-01
• Retrospective Analysis of Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia Treated with FLAG at a Comprehensive Cancer Center.
  Matthew E. Tenold, Benjamin N Moskoff, Rajeev Krishnan, Aaron S. Rosenberg, Rasmus T. Hoeg
  Clinical Lymphoma, Myeloma & Leukemia. 2021-07-01
• 2 citations
  An evaluation of venetoclax in combination with azacitidine, decitabine, or low-dose cytarabine as therapy for acute myeloid leukemia.
  Tamer Othman, Matthew E. Tenold, Benjamin N Moskoff, Tali Azenkot, Brian A. Jonas
  Expert Review of Hematology. 2021-06-15

Books/Book Chapters

• ASCO Education 
  Chapter: Current Approaches to the Treatment of Advanced or Metastatic Renal Cell Carcinoma 
  Matthew Tenold, MD; Praful Ravi, MD; Monika Kumar, MD; Alex Bowman, MD; Hans Hammers, MD, PhD ; Toni K. Choueiri, MD ; and Primo N. Lara Jr., MDAmerican Society of Clinical OncologyEdition 2020,2020

Abstracts/Posters

• Retrospective Analysis of Adults with Acute Myeloid Leukemia Treated with Venetoclax Plus Hypomethylating Agents at a Comprehensive Cancer Center
  Matthew Tenold, MD BS, Benjamin Moskoff, PharmD, David Benjamin, MD, Brian A. Jonas, MD PhD, American Society of Hematology, San Diego, 11/29/2018
• Retrospective Analysis of Adult Relapsed and Refractory Acute Leukemia Patients Treated with FLAG at a Comprehensive Cancer Cente
  Matthew Tenold, MD, Benjamin Moskoff, PharmD, Rajeev Krishnan, MD, Aaron Seth Rosenberg, MD, Brian A Jonas, MD PhD, American Society of Hematology, Atlanta, GA, 12/7/2017